Skip to content

Evaluation of pulmonary rehabilitation training in patients with chronic obstructive pulmonary disease complicated with obstructive sleep apnea hypopnea syndrome: a 12-week, single center, double-blind, randomized controlled study

Evaluation of pulmonary rehabilitation training in patients with chronic obstructive pulmonary disease complicated with obstructive sleep apnea hypopnea syndrome: a 12-week, single center, double-blind, randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052959
Enrollment
Unknown
Registered
2021-11-06
Start date
2021-11-08
Completion date
Unknown
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation

Interventions

Intervention group:12-week standard pulmonary rehabilitation
contron Group:none

Sponsors

The University of Hong Kong-Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Before any assessment, the patient or his legal representative must sign an informed consent; 2. Patients with stable COPD diagnosis; 3. Patients diagnosed with OSA; 4. Aged 18-75 years, male or female.

Exclusion criteria

Exclusion criteria: 1. History of lung cancer, cystic fibrosis, bronchiectasis or alpha-1 antitrypsin deficiency or any other significant lung disease; 2. Diagnosed as bronchial asthma, restrictive lung disease; 3. Patients who currently have or have had uncontrolled heart failure, clinically significant coronary artery disease, recent myocardial infarction, or severe hypertension that is considered uncontrolled arrhythmia; 4. Suffering from clinically or functionally uncontrollable respiratory, hematological, immunological, renal, neurological, hepatic, endocrine or other diseases or any other possible conditions (such as major surgery), which, in the judgment of the investigator, may cause The patient is at undue risk or affects the study results or interpretation of the results; 5. Patients with chronic obstructive pulmonary disease who have undergone interventional therapy, such as tracheal valve volume reduction surgery; 6. Patients with mental illnesses such as depression and anxiety disorders that affect the judgment results; 7. Conditions that prevent patients from participating in exercise in patients who cannot tolerate pulmonary rehabilitation therapy (such as severe arthritis, musculoskeletal diseases, neurological impairment, cognitive or psychosocial disorders); 8. Patients who are still smoking; 9. Patients who cannot comply with study procedures.

Design outcomes

Primary

MeasureTime frame
6-minute walk test;

Countries

China

Contacts

Public ContactWang Hongxia

The University of Hong Kong-Shenzhen Hospital

wanghx5@hku-szh.org+86 13528460931

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026